[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100132066":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":29,"centralContacts":28,"locations":33,"responsibleParty":154,"collaborators":28,"id":156,"slug":157,"hasResults":158,"nctId":159,"briefTitle":160,"officialTitle":161,"acronym":28,"eligibilityCriteria":162,"healthyVolunteers":163,"sex":164,"minAge":28,"maxAge":165,"enrollmentInfo":166,"targetDuration":28,"studyType":169,"phases":170,"briefSummary":172,"conditions":173,"keywords":28,"overallStatus":175,"whyStopped":28,"lastUpdateSubmitDate":176,"lastUpdatePostDateStruct":177,"startDateStruct":179,"completionDateStruct":181,"leadSponsor":183,"locationsCount":184},{"fullName":5,"class":6},"Hoffmann-La Roche","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Oseltamivir 3 mg","EXPERIMENTAL","infants 3 to \\\u003C12 months",[13],"Drug: Tamiflu",{"label":15,"type":10,"description":16,"interventionNames":17},"Oseltamivir 2.5 mg","infants 1 to \\\u003C3 months of age",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Oseltamivir 2 mg","infants 0 to 30 days (post natal) of age",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"DRUG","Tamiflu","oral repeating dose",[19,15,9],null,[30],{"name":31,"affiliation":5,"role":32},"Clinical Trials","STUDY_DIRECTOR",[34,46,57,68,77,86,98,109,115,124,133,145],{"facility":35,"status":28,"city":36,"state":28,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":28},"Cliniques Universitaires St-Luc","Brussels","1200","Belgium","BE",{"type":41,"coordinates":42},"Point",[43,44],4.34878,50.85045,{"lat":44,"lon":43},{"facility":47,"status":28,"city":48,"state":28,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":56,"contacts":28},"Hôpital Femme Mère Enfant; Service de rhumatologie pédiatrique","Bron","69677","France","FR",{"type":41,"coordinates":53},[54,55],4.91303,45.73865,{"lat":55,"lon":54},{"facility":58,"status":28,"city":59,"state":28,"zip":60,"country":61,"countryCode":62,"cosmosGeoPoint":63,"geoPoint":67,"contacts":28},"CAMPUS VIRCHOW-KLINIKUM CharitéCentrum 17 Klinik f.Pädiatrie Abt.Pneumologie u.Immunologie","Berlin","13353","Germany","DE",{"type":41,"coordinates":64},[65,66],13.41053,52.52437,{"lat":66,"lon":65},{"facility":69,"status":28,"city":70,"state":28,"zip":71,"country":61,"countryCode":62,"cosmosGeoPoint":72,"geoPoint":76,"contacts":28},"LWL-Klinik-Bochum","Bochum","44792",{"type":41,"coordinates":73},[74,75],7.21648,51.48165,{"lat":75,"lon":74},{"facility":78,"status":28,"city":79,"state":28,"zip":80,"country":61,"countryCode":62,"cosmosGeoPoint":81,"geoPoint":85,"contacts":28},"Onkologische Schwerpunktpraxis Dr. Med. O. Burkhard & B. Reimann","Worms","67547",{"type":41,"coordinates":82},[83,84],8.35916,49.63278,{"lat":84,"lon":83},{"facility":87,"status":28,"city":88,"state":89,"zip":90,"country":91,"countryCode":92,"cosmosGeoPoint":93,"geoPoint":97,"contacts":28},"Fondazione Ospedale Maggiore Policlinico","Milan","Lombardy","20122","Italy","IT",{"type":41,"coordinates":94},[95,96],9.18951,45.46427,{"lat":96,"lon":95},{"facility":99,"status":28,"city":100,"state":28,"zip":101,"country":102,"countryCode":103,"cosmosGeoPoint":104,"geoPoint":108,"contacts":28},"Vitamed","Bydgoszcz","85-021","Poland","PL",{"type":41,"coordinates":105},[106,107],18.00762,53.1235,{"lat":107,"lon":106},{"facility":110,"status":28,"city":100,"state":28,"zip":111,"country":102,"countryCode":103,"cosmosGeoPoint":112,"geoPoint":114,"contacts":28},"Samodzielny Publiczny Zakład Opieki; Wcześniaków I Intensywnej Terapii","85-168",{"type":41,"coordinates":113},[106,107],{"lat":107,"lon":106},{"facility":116,"status":28,"city":117,"state":28,"zip":118,"country":102,"countryCode":103,"cosmosGeoPoint":119,"geoPoint":123,"contacts":28},"Zespol Opieki Zdrowotnej Debica; Oddzial Dzieciecy","Dębica","39-200",{"type":41,"coordinates":120},[121,122],21.41141,50.05146,{"lat":122,"lon":121},{"facility":125,"status":28,"city":126,"state":28,"zip":127,"country":102,"countryCode":103,"cosmosGeoPoint":128,"geoPoint":132,"contacts":28},"St Hedwig Hospital In Trzebnica","Trzebnica","55-100",{"type":41,"coordinates":129},[130,131],17.06331,51.31076,{"lat":131,"lon":130},{"facility":134,"status":28,"city":135,"state":136,"zip":137,"country":138,"countryCode":139,"cosmosGeoPoint":140,"geoPoint":144,"contacts":28},"Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas","Santiago de Compostela","La Coruña","15706","Spain","ES",{"type":41,"coordinates":141},[142,143],-8.54569,42.88052,{"lat":143,"lon":142},{"facility":146,"status":28,"city":147,"state":147,"zip":148,"country":138,"countryCode":139,"cosmosGeoPoint":149,"geoPoint":153,"contacts":28},"Hospital Universitario de Getafe; Servicio de Pediatria","Madrid","28905",{"type":41,"coordinates":150},[151,152],-3.70256,40.4165,{"lat":152,"lon":151},{"type":155,"investigatorFullName":28,"investigatorTitle":28,"investigatorAffiliation":28,"oldNameTitle":28,"oldOrganization":28},"SPONSOR","100132066","phase-1-a-pharmacokineticpharmacodynamic-pkpd-and-safety-evaluation-of-oseltamivir-tamiflu-in-the-treatment-of-infants-0-to-12-months-of-age-with-confirmed-flu-infection-100132066",true,"NCT00988325","A Pharmacokinetic\u002FPharmacodynamic (PK\u002FPD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to \u003C12 Months of Age With Confirmed Flu Infection","An Open Label, Prospective, Pharmacokinetic\u002FPharmacodynamic and Safety Evaluation of Oseltamivir (Tamiflu®) in the Treatment of Infants 0 to \u003C12 Months of Age With Confirmed Influenza Infection","Inclusion Criteria:\n\n* infants \\\u003C\u002F=12 months of age\n* laboratory confirmed diagnosis of influenza within 96 hours prior to first dose\n* influenza symptoms for \\\u003C\u002F=96 hours prior to first dose\n\nExclusion Criteria:\n\n* preterm infants less than 40 weeks (corrected for gestational age)\n* weight less than 5th percentile for age (corrected for gestational age)\n* concurrent gastrointestinal conditions that preclude enteric absorption of the drug\n* bronchopulmonary dysplasia\u002Fchronic lung disease on assisted ventilation at time of enrollment\n* active or uncontrolled respiratory, cardiac, hepatic, CNS or renal disease at baseline\n* symptomatic inborn errors of metabolism",false,"ALL","12 Months",{"count":167,"type":168},65,"ACTUAL","INTERVENTIONAL",[171],"PHASE1","This study will assess the pharmacokinetics\u002Fpharmacodynamics and safety of oseltamivir \\[Tamiflu\\] therapy in infants less than 1 year of age with influenza diagnosed in the 96 hours prior to the first dose. Patients age 3-12 months will receive 3 mg\u002Fkg, 1-3 months will receive 2.5 mg\u002Fkg, and birth to 1 month will receive 2 mg\u002Fkg twice a day for a total of 10 doses. Patients positive for influenza virus on Day 6 will be eligible to receive continued study treatment for an additional 10 doses (5 days). The anticipated time on study treatment is 4 weeks, and the target sample size is 65-85 male and female infants.",[174],"Influenza","COMPLETED","2017-01-30",{"date":178,"type":168},"2017-03-20",{"date":180,"type":28},"2011-01",{"date":182,"type":168},"2012-04",{"name":5,"class":6},12]